Abstract:Neoantigens, HLA bound peptides generated by tumor-specific mutations, have emerged as promising targets for cancer immunotherapeutic. However, the significant challenge in neoantigen-based therapies is that the neoantigens are rare and difficult to predict. Therefore, in addition to prediction algorithms, the optimization of validation methods is essential for the reliable selection of highly immunogenic neoepitopes. In this study, we have developed a cost-effective screening method to validate large scale of neoantigen candidates. The DNA library-based methods have been employed for antigen selection and T cell receptor identification. We improved the DNA library-based neoantigen screening method by adding two barcodes to each minigene transcribing multiple neoantigen candidates and pooled synthesis of minigenes. We initially designed the barcodes to allow analysis in a 10 by 10 format for screening of hundreds of neoantigens so that PCR with each barcode result in amplification of ten candidates. The second barcode allowed the deconvolution of immunogenicity results without the need for synthesis of individual peptides. In this method B cell was used as antigen-presenting cell, which were co-transfected with mRNA for a minigene pool, 41BBL, and OX40L after expansion with CD40L/IL4/IL21. The resulting B cells were co-cultured with T cells and T cell responses were evaluated using ELISpot. To validate the method the TESLA consortium reported tetramer positive neoantigens were included in minigene. In results, the neoantigens including each barcode were amplified to form a pool of ten neoantigens as a minigene and confirmed that the neoantigens were equally amplified by nested PCR. The neoantigen pools synthesized as mRNA were transfected for presentation in B cells. The result of the targeting a neoantigen pool containing tetramer-positive neoantigens of the TESLA consortium showed a positive for ELISpot. In conclusion, our optimized screening method, employing the double barcode system, offers a time- and cost-efficient approach for the selection of immunogenic neoantigens without the need for individual peptides. This method will facilitate large-scale screening to identify actual neoantigens with immunogenic potential, contributing to the development of neoantigen-targeted vaccines. Citation Format: Seong Gwang Kim, Min-Ho Jung, Hyun-Ji Hwang, Sejin Oh, Seong-Eui Hong, Soonmyung Paik, Hae-Suk Kim. An enhanced and cost-efficient method for neoantigen immunogenicity screening method: Double Barcode Neoepitope ScanTM [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 3110.

Microfluidic-enabled production of DNA barcoded APC library (MEDAL) for high throughput T cell epitope screening

Multiplex in Situ Tagging Technology for Highly Multiplexed Single-Cell Analysis

Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification

High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange

High-throughput and multimodal profiling of antigen-specific T cells with a droplet-based cell-cell interaction screening platform

Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries

An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening

Barcoded Microchips for Biomolecular Assays

Efficient Screening of Combinatorial Peptide Libraries by Spatially Ordered Beads Immobilized on Conventional Glass Slides

Preparation empty peptide-receptive MHC class I complex for large-scale detection through photolabile peptide ligands

Bimodal Imprint Chips For Peptide Screening: Integration Of High-Throughput Sequencing By Ms And Affinity Analyses By Surface Plasmon Resonance Imaging

High-Throughput Functional Screening of Antigen-Specific T Cells Based on Droplet Microfluidics at a Single-Cell Level

A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells

Proteomic Barcoding Platform for Macromolecular Screening and Delivery

Abstract 3110: An enhanced and cost-efficient method for neoantigen immunogenicity screening method: Double Barcode Neoepitope ScanTM

Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery

Spatial barcoding-enabled highly multiplexed immunoassay with digital microfluidics

High-throughput antibody screening with high-quality factor nanophotonics and bioprinting

Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping

A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines

Screening T-Cell Activity via a Photodetachable DNA-Copolymer Nanocage and Its Therapeutic Application